General description
INN
Ustekinumab
ATC codes
Medicine type
Biological agent
EML status history
Application rejected in 2023
(TRS
1049)
for
Psoriasis of unspecified type
Added in 2025
(TRS
1064)
for
Psoriasis of unspecified type
Wikipedia
DrugBank
Recommendations
Section
Dermatological medicines > Medicines affecting skin differentiation and proliferation
- Parenteral > General injections > SC: 45 mg per 0.5 mL in vial; 45 mg per 0.5 mL in pre-filled syringe; 45 mg per 0.5 mL in pre-filled pen; 90 mg per mL in pre-filled syringe; 90 mg per mL in pre-filled pen
Indications